Ligand · VHC
VHC · 4-amino-20,22-dimethyl-13-oxa-7-thia-3,5,17-triazatetracyclo[17.3.1.1~2,6~.1~8,12~]pentacosa-1(23),2(25),3,5,8(24),9,11,19,21-nonaen-18-one
VHC, 4-amino-20,22-dimethyl-13-oxa-7-thia-3,5,17-triazatetracyclo[17.3.1.1~2,6~.1~8,12~]pentacosa-1(23),2(25),3,5,8(24),9,11,19,21-nonaen-18-one (C22 H22 N4 O2 S, 406.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1…
- Component
- VHC
- Formula
- C22 H22 N4 O2 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VHC in 2 structures; the first of them:
- 3VHC · Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor · VHC A1 · binds ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97, MET98 and 10 more
- 3VHC · HSP90 alpha N-terminal domain in complex with a macrocyclic inhibitor · VHC A1 · binds ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97, MET98 and 10 more
Residues it binds most
ASN 2, ASP 2, GLY 2, LYS 2, VAL 2, ALA 2, ILE 2, LEU 2, MET 2, PHE 2 (residue and the binding sites it lines).
Found with
- MG · Magnesium ion
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.